Ian J Lobo
Examiner (ID: 16049, Phone: (571)272-6974 , Office: P/3645 )
Most Active Art Unit | 3645 |
Art Unit(s) | 3662, 3641, 2202, 3642, 2838, 2201, 3645, 2899 |
Total Applications | 3412 |
Issued Applications | 2797 |
Pending Applications | 152 |
Abandoned Applications | 463 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 923039
[patent_doc_number] => 07319011
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-01-15
[patent_title] => 'Method for distinguishing follicular thyroid adenoma (FTA) from follicular thyroid carcinoma (FTC)'
[patent_app_type] => utility
[patent_app_number] => 11/100640
[patent_app_country] => US
[patent_app_date] => 2005-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10957
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/319/07319011.pdf
[firstpage_image] =>[orig_patent_app_number] => 11100640
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/100640 | Method for distinguishing follicular thyroid adenoma (FTA) from follicular thyroid carcinoma (FTC) | Apr 6, 2005 | Issued |
Array
(
[id] => 7121996
[patent_doc_number] => 20050013825
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-20
[patent_title] => 'Vaccine containing the catalytic subunit of telomerase for treating cancer'
[patent_app_type] => utility
[patent_app_number] => 10/877146
[patent_app_country] => US
[patent_app_date] => 2004-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 104
[patent_figures_cnt] => 104
[patent_no_of_words] => 103028
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10877146
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/877146 | Vaccine containing the catalytic subunit of telomerase for treating cancer | Jun 23, 2004 | Abandoned |
Array
(
[id] => 7082688
[patent_doc_number] => 20050048068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-03
[patent_title] => 'Therapeutic compounds for ovarian cancer'
[patent_app_type] => utility
[patent_app_number] => 10/813859
[patent_app_country] => US
[patent_app_date] => 2004-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19390
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20050048068.pdf
[firstpage_image] =>[orig_patent_app_number] => 10813859
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/813859 | Therapeutic compounds for ovarian cancer | Mar 30, 2004 | Abandoned |
Array
(
[id] => 7024937
[patent_doc_number] => 20050019331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-27
[patent_title] => 'Synthetic peptide neutrophil cell chemotactic agents'
[patent_app_type] => utility
[patent_app_number] => 10/718930
[patent_app_country] => US
[patent_app_date] => 2003-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4697
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20050019331.pdf
[firstpage_image] =>[orig_patent_app_number] => 10718930
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/718930 | Synthetic peptide neutrophil cell chemotactic agents | Nov 19, 2003 | Abandoned |
Array
(
[id] => 7289340
[patent_doc_number] => 20040110219
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-10
[patent_title] => 'Methods for diagnosis and therapy of pancreatic cancer and composition useful therein'
[patent_app_type] => new
[patent_app_number] => 10/696487
[patent_app_country] => US
[patent_app_date] => 2003-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6113
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20040110219.pdf
[firstpage_image] =>[orig_patent_app_number] => 10696487
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/696487 | Methods for diagnosis and therapy of pancreatic cancer and composition useful therein | Oct 28, 2003 | Issued |
Array
(
[id] => 7199054
[patent_doc_number] => 20040086455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-06
[patent_title] => 'Detection and treatment of cancer'
[patent_app_type] => new
[patent_app_number] => 10/688464
[patent_app_country] => US
[patent_app_date] => 2003-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10442
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20040086455.pdf
[firstpage_image] =>[orig_patent_app_number] => 10688464
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/688464 | Detection and treatment of cancer | Oct 16, 2003 | Abandoned |
Array
(
[id] => 6905604
[patent_doc_number] => 20050100999
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-12
[patent_title] => 'Nucleic acid encoding receptor type protein kinase'
[patent_app_type] => utility
[patent_app_number] => 10/653147
[patent_app_country] => US
[patent_app_date] => 2003-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6878
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20050100999.pdf
[firstpage_image] =>[orig_patent_app_number] => 10653147
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/653147 | Nucleic acid encoding receptor type protein kinase | Sep 2, 2003 | Abandoned |
Array
(
[id] => 7083114
[patent_doc_number] => 20050048494
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-03
[patent_title] => 'Colorectal cancer prognostics'
[patent_app_type] => utility
[patent_app_number] => 10/651237
[patent_app_country] => US
[patent_app_date] => 2003-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7951
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20050048494.pdf
[firstpage_image] =>[orig_patent_app_number] => 10651237
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/651237 | Colorectal cancer prognostics | Aug 26, 2003 | Abandoned |
10/332923 | Method of detecting an increased susceptibility to breast cancer | May 14, 2003 | Abandoned |
Array
(
[id] => 7289405
[patent_doc_number] => 20040110239
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-10
[patent_title] => 'Detection to the HER2 receptor by means of biotinilated humanized antibody'
[patent_app_type] => new
[patent_app_number] => 10/417336
[patent_app_country] => US
[patent_app_date] => 2003-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4175
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20040110239.pdf
[firstpage_image] =>[orig_patent_app_number] => 10417336
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/417336 | Detection to the HER2 receptor by means of biotinilated humanized antibody | Apr 16, 2003 | Abandoned |
Array
(
[id] => 6769921
[patent_doc_number] => 20030215861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-20
[patent_title] => 'Methods of treating a BRCA associated disorder'
[patent_app_type] => new
[patent_app_number] => 10/410207
[patent_app_country] => US
[patent_app_date] => 2003-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5627
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20030215861.pdf
[firstpage_image] =>[orig_patent_app_number] => 10410207
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/410207 | Methods of treating a BRCA associated disorder | Apr 9, 2003 | Abandoned |
Array
(
[id] => 7429009
[patent_doc_number] => 20040001789
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-01
[patent_title] => 'Cytotoxicity mediation of cells evidencing surface expression of gp96 or precursors thereof'
[patent_app_type] => new
[patent_app_number] => 10/403516
[patent_app_country] => US
[patent_app_date] => 2003-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8148
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0001/20040001789.pdf
[firstpage_image] =>[orig_patent_app_number] => 10403516
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/403516 | Cytotoxicity mediation of cells evidencing surface expression of gp96 or precursors thereof | Mar 30, 2003 | Abandoned |
Array
(
[id] => 7467539
[patent_doc_number] => 20040053830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-18
[patent_title] => 'BCMP84 protein, compositions, diagnostic and therapeutic uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/382478
[patent_app_country] => US
[patent_app_date] => 2003-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 38403
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20040053830.pdf
[firstpage_image] =>[orig_patent_app_number] => 10382478
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/382478 | BCMP84 protein, compositions, diagnostic and therapeutic uses thereof | Mar 5, 2003 | Abandoned |
Array
(
[id] => 7364835
[patent_doc_number] => 20040005644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-08
[patent_title] => 'Method and composition for detection and treatment of breast cancer'
[patent_app_type] => new
[patent_app_number] => 10/373801
[patent_app_country] => US
[patent_app_date] => 2003-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 29841
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0005/20040005644.pdf
[firstpage_image] =>[orig_patent_app_number] => 10373801
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/373801 | Method and composition for detection and treatment of breast cancer | Feb 26, 2003 | Abandoned |
Array
(
[id] => 6804662
[patent_doc_number] => 20030232056
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-18
[patent_title] => 'Compositions and methods for the therapy and diagnosis of ovarian cancer'
[patent_app_type] => new
[patent_app_number] => 10/369186
[patent_app_country] => US
[patent_app_date] => 2003-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46416
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20030232056.pdf
[firstpage_image] =>[orig_patent_app_number] => 10369186
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/369186 | Compositions and methods for the therapy and diagnosis of ovarian cancer | Feb 13, 2003 | Abandoned |
Array
(
[id] => 6769954
[patent_doc_number] => 20030215894
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-20
[patent_title] => 'Protein-induced monoclonal receptors to protein ligands'
[patent_app_type] => new
[patent_app_number] => 10/350405
[patent_app_country] => US
[patent_app_date] => 2003-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 36814
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20030215894.pdf
[firstpage_image] =>[orig_patent_app_number] => 10350405
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/350405 | Protein-induced monoclonal receptors to protein ligands | Jan 23, 2003 | Abandoned |
Array
(
[id] => 6739716
[patent_doc_number] => 20030157085
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-21
[patent_title] => 'Antitumor agents'
[patent_app_type] => new
[patent_app_number] => 10/314439
[patent_app_country] => US
[patent_app_date] => 2002-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 4526
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20030157085.pdf
[firstpage_image] =>[orig_patent_app_number] => 10314439
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/314439 | Antitumor agents | Dec 8, 2002 | Abandoned |
Array
(
[id] => 6851445
[patent_doc_number] => 20030143648
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-31
[patent_title] => 'Enzyme activity profiles'
[patent_app_type] => new
[patent_app_number] => 10/304559
[patent_app_country] => US
[patent_app_date] => 2002-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 13145
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20030143648.pdf
[firstpage_image] =>[orig_patent_app_number] => 10304559
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/304559 | Enzyme activity profiles | Nov 24, 2002 | Abandoned |
Array
(
[id] => 7395719
[patent_doc_number] => 20040022785
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-05
[patent_title] => 'Expression of herstatin, an alternative HER-2/neu product, in cells that express either p185HER-2 or the EGF receptor inhibits receptor activity and cell growth'
[patent_app_type] => new
[patent_app_number] => 10/302663
[patent_app_country] => US
[patent_app_date] => 2002-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 26201
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20040022785.pdf
[firstpage_image] =>[orig_patent_app_number] => 10302663
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/302663 | Expression of herstatin, an alternative HER-2/neu product, in cells that express either p185HER-2 or the EGF receptor inhibits receptor activity and cell growth | Nov 21, 2002 | Abandoned |
Array
(
[id] => 7329741
[patent_doc_number] => 20040254101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-16
[patent_title] => 'Colon specific gene and protein and cancer'
[patent_app_type] => new
[patent_app_number] => 10/291773
[patent_app_country] => US
[patent_app_date] => 2002-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 79201
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20040254101.pdf
[firstpage_image] =>[orig_patent_app_number] => 10291773
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/291773 | Colon specific gene and protein and cancer | Nov 11, 2002 | Abandoned |